Related Experiment Videos
Somatosensory evoked potentials in Huntington's disease
Electroencephalography and Clinical Neurophysiology
|November 1, 1982
Summary
Somatosensory evoked potentials (SEPs) reveal abnormalities in Huntington's disease (HD) patients, with altered early SEP events and prolonged P15-N20 conduction times. Some individuals at risk for HD also showed subtle SEP changes.
Area of Science:
- Neurophysiology
- Neurology
- Clinical Neuroscience
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder.
- Somatosensory evoked potentials (SEPs) are electrophysiological measures reflecting the integrity of somatosensory pathways.
- SEP analysis can potentially detect subclinical neurological alterations.
Purpose of the Study:
- To investigate SEP abnormalities in patients with Huntington's disease (HD).
- To assess SEP characteristics in individuals at risk (AR) for HD.
- To compare SEP findings between HD patients, AR individuals, and healthy controls.
Main Methods:
- Scalp-recorded SEPs were elicited by median nerve stimulation.
- Participants included 21 HD patients, 14 AR individuals, and 21 age/sex-matched controls.
- Analysis focused on peak latencies, component presence, and spatial distribution of SEPs.
Main Results:
- No HD patient exhibited completely normal SEPs; abnormalities included amplitude reduction and absence of late components.
- Specific early SEP deviations were observed in HD patients, including altered P30/P45 peaks and prolonged P15-N20 conduction time.
- Most AR individuals had normal SEPs, but 4 showed prolonged P15-N20 latency differences, and mean amplitudes were lower than controls.
Conclusions:
- SEP abnormalities are present in Huntington's disease, affecting both early and late components.
- Prolonged P15-N20 conduction time is a significant finding in HD patients.
- Subtle SEP alterations may indicate early neuropathological changes in individuals at risk for HD.